Relationships between symptoms of schizophrenia and substance abuse

Journal of Nervous and Mental Disease

Volumn 185, Issue 1, 1997, Pages 13-20

  Brunette, Mary F ^b   Mueser, Kim T ^b   Drake, Robert E ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOREGULATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; SCHIZOPHRENIA; SUBSTANCE ABUSE; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; ALCOHOLISM; AMBULATORY CARE; COMORBIDITY; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HUMANS; INSTITUTIONALIZATION; MALE; MARIJUANA ABUSE; MIDDLE AGED; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF MEDICATION; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS;

EID: 0031024780     PISSN: 00223018     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005053-199701000-00003     Document Type: Article

References (71)

1. Abram KM, Teplin LA (1991) Co-occurring disorders among mentally ill jail detainees: Implications for public policy. Am Psychologist 40:1036-1045.
2. Alterman AI, Ayre FR, Williford WO (1984) Diagnostic validation of conjoint schizophrenia and alcoholism. J Clin Psychiatry 5:300-303.
3. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, (3rd rev ed) (DSM-III-R). Washington, DC: Author.
4. Angrist B, Rotrosen J, Gershon S (1980) Differential effects of amphetamine and neuroleptics on negative and positive symptoms in schizophrenia. Psychopharmacology 72:17-19.
5. Arndt S, Tyrrell G, Flaum M, Andreasen NC (1992) Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment. Psychol Med 22:379-388.
6. Barbee JG, Clark PD, Crapanzano MS, Heintz GC, Kehoe CE (1989) Alcohol and substance abuse among schizophrenic patients presenting to an emergency psychiatric service. J Nerv Ment Dis 177:400-407.
7. Bartels SJ, Drake RE, Wallach MA, Freeman DH (1991) Characteristic hostility in schizophrenic outpatients. Schizophr Bull 17:163-171.
8. Belcher JR (1989) On becoming homeless: A study of chronically mentally ill persons. J Community Psychol 17:173-185.
9. Berger PA, Watson SJ, Akil H (1980) Beta-endorphin and schizophrenia. Arch Gen Psychiatry 37:642-647.
10. Bergman HC, Harris M (1985) Substance abuse among young adult chronic patients. Psychosoc Rehabil J 9:49-54.
11. Brady KT, Killeen T, Jarrell P (1993) Depression in alcoholic schizophrenic patients. Am J Psychiatry 150:1255-56.
12. Breakey WR, Goodell H, Lorenz PC, McHugh PR (1974) Hallucinogenic drugs as precipitants of schizophrenia. Psychol Med 4:255-260.
13. Brizer DA, Hartmen N, Sweeney J, Millman RB (1985) Effect of methadone plus neuroleptics on treatment-resistant chronic paranoid schizophrenics. Am J Psychiatry 142:1106-1107.
14. Buckley P, Thompson P, Way L, Meltzer HY (1994) Substance abuse among patients with treatment-resistant schizophrenia: Characteristics and implications for clozapine therapy. Am J Psychiatry 151:385-389.
15. Carpenter MD, Mulligan JC, Bader IA, Meinzer AE (1985) Multiple admissions to an urban psychiatric center. Hosp Community Psychiatry 36:1305-1308.
16. Center for Mental Health Services (1994) Making a difference: Interim status report of the McKinney Research Demonstration Program for Homeless Mentally Ill Adults. Rockville, MD: Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services.
17. Cesarec Z, Nyman AK (1985) Differential response to amphetamine in schizophrenia. Acta Psychiatr Scand 71:523-528.
18. Clark RE (1994) Family costs associated with severe mental illness. Hosp Community Psychiatry 45:808-813.
19. Cleghorn JM, Kaplan RD, Szechtman B, Szechtman H, Brown GM, Franco S (1991) Substance abuse and schizophrenia: Effect on symptoms but not on neurocognitive function. J Clin Psychiatry 52:26-30.
20. Cohen J, Cohen P (1983) Applied Multiple Regression. Correlation Analysis for the Social Sciences, (2nd ed), Hillsdale, NJ: Lawrence Erlbaum.
21. Convit A, Nemes Z, Volavka J (1988) History of phencyclidine use and repeated assaults in newly admitted young schizophrenic men. Am J Psychiatry 145:1176.
22. Craig TJ, Lin SP, El-Defrawi MH, Goodman AB (1985) Clinical correlates of readmission in a schizophrenic cohort. Psychiatry Q 57:5-10.
23. Crowley TJ, Chesluk D, Dilts S, Hart R (1974) Drug and alcohol abuse among psychiatric admissions. Arch Gen Psychiatry 30: 13-20.
24. Cuffel BJ, Chase P (1994) Remission and relapse of substance use disorders in schizophrenia: Results from a one year prospective study. J Nerv Ment Dis 182:342-348.
25. Cuffel BJ, Heithoff KA, Lawson W (1993) Correlates of patterns of substance abuse among patents with schizophrenia. Hosp Community Psychiatry 44:247-251.
26. Cuffel BJ, Shumway M, Chouljian TL, Macdonald T (1994) A longitudinal study of substance use and community violence in schizophrenia. J Nerv Ment Dis 182:704-708.
27. Davis GC, Bunney WE, DeFraites EG, Kleinman JE, van Kammen DP, Post RM, Wyatt RJ (1977) Intravenous naloxone administration in schizophrenia and affective illness. Science 197: 74-77.
28. Dixon L, Haas G, Weiden P, Sweeney J, Frances A (1990) Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports. Schizophr Bull 16:69-79.
29. Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ (1991) Drug abuse in schizophrenic patients: Clinical correlates and reasons for use. Am J Psychiatry 149:224-230.
30. Dixon L, McNary S, Lehman A (1995) Substance abuse and family relationships of persons with severe mental illness. Am J Psychiatry 152:456-458.
31. Douyon R, Angrist B, Peselow E, Cooper T, Rotrosen J (1989) Neuroleptic augmentation with alprazolam: Clinical effects and pharmacokinetic correlates. Am J Psychiatry 146:231-234.
32. Drake RE, Alterman AI, Rosenberg SD (1993) Detection of substance use disorders in severely mentally ill patients. Community Ment Health J 29:175-192.
33. Drake RE, Mueser KT, McHugo GJ (1995) Using clinician rating scales to assess substance abuse among persons with severe mental disorders. In LI Sederer, B Dickey (Eds), Outcomes assessment in clinical practice. Baltimore: Williams and Wilkins.
34. Drake RE, Osher FC, Wallach MA (1989) Alcohol use and abuse in schizophrenia. J Nerv Ment Dis 177:408-413.
35. Drake RD, Osher FC, Wallach MA (1991) Homelessness and dual diagnosis. Am Psychol 46:1149-1158.
36. Freed EX (1975) Alcoholism and schizophrenia: The search for perspectives. J Stud Alcohol 36:853-879.
37. Gershon ES, DeLisi LE, Hamovit J, Nurnberger JI, Maxwell ME, Schreiber J, Dauphinais D, Dingman CW, Guroff JJ (1988) A controlled family study of chronic psychoses. Arch Gen Psychiatry 45:328-336.
38. Hamera E, Schneider JK, Stanley S (1995) Alcohol, cannabis, nicotine, and caffeine use and symptom distress in schizophrenia. J Nerv Ment Dis 183:559-565.
39. Hays P, Aidroos N (1986) Alcoholism followed by schizophrenia. Acta Psychiatr Scand 74:187-189.
40. Haywood TW, Kravitz HM, Grossman LS, Cavanaugh JL, Davis JM, Lewis DA (1995) Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. Am J Psychiatry 152:856-861.
41. Hoch DH (1952) Experimentally produced psychoses. Am J Psychiatry 107:607-611.
42. Janowski DS, Davis JM (1976) Methylphenidate, dextroamphetamine, and levamphetamine: Effects on schizophrenic symptoms. Arch Gen Psychiatry 33:304-308.
43. Jimerson DC, van Kammen DP, Post RM, Docherty JP, Bunney WE (1982) Diazepam in schizophrenia: A preliminary double-blind trial. Am J Psychiatry 139:489-491.
44. Kendler KS (1985) A twin study of individuals with both schizophrenia and alcoholism. Br J Psychiatry 147:48-53.
45. Khantzian E (1985) The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence. Am J Psychiatry 142:1259-1264.
46. Knudsen P, Vilmar T (1984) Cannabis and neuroleptic agents in schizophrenia. Acta Psychiatr Scand 69:162-174.
47. Linszen DH, Dingemans PM, Lenior ME (1994) Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 51:273-279.
48. Lysaker P, Bell M, Beam-Goulet J, Milstein R (1994) Relationship of positive and negative symptoms to cocaine abuse in schizophrenia. J Nerv Ment Dis 182:109-112.
49. McLellan AT, Luborsky L, Woody GE, O'Brien CP (1980) An improved evaluation instrument for substance abuse patients: The Addiction Severity Index. J Nerv Ment Dis 16:826-833.
50. Mueser KT, Drake RE, Miles K (in press) The course and treatment of substance use disorder in patients with severe mental illness. National Institute of Drug Abuse research monographs. Rockville, MD: National Institute on Drug Abuse.
51. Mueser KT, Nishith P, Tracey JI, DeGirolamo J, Molinaro M (1995) Expectations and Motives for Substance Use in Schizophrenia. Schizophr Bull 21:367-378.
52. Mueser KT, Yarnold PR, Levinson DF, Singh H, Bellack AS, Kee K, Morrison RL, Yadalam KG (1990) Prevalence of substance abuse in schizophrenia: Demographic and clinical correlates. Schizophr Bull 16:31-56.
53. Negrete JC, Knapp WP, Douglas DE, Smith WB (1986) Cannabis affects the severity of schizophrenic symptoms: Results of a clinical survey. Psychol Med 16:515-520.
54. Noordsy DL, Drake RE, Biesanz JC, McHugo GJ (1994) Family history of alcoholism in schizophrenia. J Nerv Ment Dis 182: 651-655.
55. Noordsy DL, Drake RE, Teague GB, Osher FC, Hurlbut SC, Beaudett MS (1991) Subjective experiences related to alcohol use among schizophrenics. J Nerv Ment Dis 179:410-414.
56. Osher FC, Drake RE, Noordsy DL, Teague GB, Hurlbut SC, Biesanz JC, Beaudett MS (1994) Correlates and outcomes of alcohol use disorder among rural outpatients with schizophrenia. J Clin Psychiatry 55:109-113.
57. Pennes HH (1954) Clinical reactions of schizophrenics to sodium amytal, pervitin hydrochloride, mescaline sulfate, and D-lysergic acid diethylamide (LSD25). J Nerv Ment Dis 119:95-112.
58. Pulver AE, Wolyniec PS, Wagner MG, Moorman CC, McGrath JA (1989) An epidemiologic investigation of alcohol-dependent schizophrenics. Acta Psychiatr Scand 603-612.
59. Regier AR, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK (1990) Comorbidity of mental disorders with alcohol and other drug abuse. JAMA 264:2511-2518.
60. Richard ML, Liskow BI, Perry PJ (1985) Recent psychostimulant use in hospitalized schizophrenics. J Clin Psychiatry 46:79-83.
61. Rosenthal RN, Hellerstein KJ, Miner CR (1994) Positive and negative syndrome typology in schizophrenic patients with psychoactive substance use disorders. Compr Psychiatry 35:91-98.
62. Safer KJ (1987) Substance abuse by young adult chronic patients. Hosp Community Psychiatry 38:511-514.
63. Serper MR, Alpert M, Richardson NA, Dickson S, Allen MH, Werner A (1995) Clinical effects of recent cocaine use on patients with acute schizophrenia. Am J Psychiatry 152:1464-1469.
64. Sevy S, Kay SR, Opler LA, van Praag HM (1990) Significance of cocaine history in schizophrenia. J Nerv Ment Dis 178:642-648.
65. Shaner A, Eckman TA, Roberts LJ, Wilkins JN, Tucker D, Tsuang JW, Mintz J (1995) Disability income, cocaine use and repeated hospitalization among schizophrenic cocaine abusers: A government-sponsored revolving door? New Engl J Med 333:777-783.
66. Sobell MB, Maisto SA, Sobell LC, Cooper AM, Cooper T, Sanders B (1980) Developing a prototype for evaluating alcohol treatment effectiveness. In LC Sobell, BM Sobell, E Ward (Eds), Evaluating alcohol and drug abuse treatment effectiveness. New York: Pergamon Press.
67. Soni SD, Bownlee M (1991) Alcohol abuse in chronic schizophrenics: Implications for management in the community. Acta Psychiatr Scand 84:272-276.
68. Spitzer RL, Williams JBW, Gibbon M, First MB (1990) Structured Clinical Interview for DSMIII-R - Patient Edition. Washington, DC: American Psychiatric Press.
69. Swanson JS, Holzer CE, Ganju VK, Jono RT (1990) Violence and psychiatric disorder in the community: Evidence from the epidemiologic catchment area surveys. Hasp Community Psychiatry 41:761-770.
70. Test MA, Yallisch LS, Allness DJ, Ripp K (1989) Substance use in young adults with schizophrenics disorders. Schizophr Bull 15:465-476.
71. Treffert DA (1978) Marijuana use in schizophrenia: A clear hazard. Am J Psychiatry 135:1213-1215.